Outpatient Weekly Chemotherapy and Radiotherapy for Nasopharyngeal Carcinoma
Author Information
Author(s): Lin J-C, Jan J-S, Hsu C-Y, Jiang R-S, Wang W-Y
Primary Institution: Taichung Veterans General Hospital
Hypothesis
Can outpatient weekly neoadjuvant chemotherapy combined with radiotherapy improve treatment outcomes for advanced nasopharyngeal carcinoma?
Conclusion
The study found high complete response rates and low toxicity in patients treated with outpatient weekly neoadjuvant chemotherapy followed by radiotherapy for advanced nasopharyngeal carcinoma.
Supporting Evidence
- 57.8% of patients achieved a complete response after treatment.
- Only 3 out of 90 patients experienced local recurrence.
- Acute toxicity was mild and well tolerated by the majority of patients.
Takeaway
This study shows that giving chemotherapy before radiation can help patients with a type of throat cancer feel better and have fewer side effects.
Methodology
Patients received outpatient weekly neoadjuvant chemotherapy followed by radiotherapy, with assessments of toxicity and tumor response.
Potential Biases
Potential selection bias due to the specific eligibility criteria for patient inclusion.
Limitations
The follow-up period was relatively short, and the study was conducted at a single institution.
Participant Demographics
{"age_range":"24–71","median_age":43,"sex_distribution":{"male":66,"female":24},"karnofsky_performance_status":{"≥80%":82,"<80%":8}}
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website